首页> 外文期刊>American Journal of Cancer Research >S100A14, a mediator of epithelial-mesenchymal transition, regulates proliferation, migration and invasion of human cervical cancer cells
【24h】

S100A14, a mediator of epithelial-mesenchymal transition, regulates proliferation, migration and invasion of human cervical cancer cells

机译:S100A14,上皮-间质转化的介体,调节人宫颈癌细胞的增殖,迁移和侵袭

获取原文
获取外文期刊封面目录资料

摘要

S100A14 is an EF-hand calcium-binding protein that has been reported to exert its biological effects on different types of cells. However, the potential clinical significance and biological functions of S100A14 in cervical cancer has not yet been clarified. In this study, we firstly examined the correlation between S100A14 expression and clinical-pathological parameters in cervical cancers. Next, we observed the effect of S100A14 on cell cycle progression, cell proliferation, migration and invasion by employing lentiviral-mediated overexpression and knockdown of S100A14 in cervical cancer cells. Furthermore, we investigated the underlying mechanism of S100A14 affecting cell migration and invasion. Immunohistochemistry analysis demonstrated that S100A14 expression was associated with the International Federation of Gynecology and Obstetrics (FIGO) stage (emP/em = 0.025) and lymph node (LN) metastasis (emP/em = 0.001). Functional assays showed that S100A14 overexpression increased the proportion of G2/M phase, promoted cell proliferation, migration, and invasion, whereas S100A14 knockdown exhibited adverse effect on above properties. Mechanistic investigation demonstrated that S100A14 can act as a mediator of epithelial-mesenchymal transition (EMT). And overexpression of S100A14 increased expression of emN/em-cadherin and Vimentin while decreased expression of emE/em-cadherin. The opposite results were observed in S100A14-silenced cells. Taken together, our data indicate that S100A14 has a crucial role in cervical cancer progression. This study significantly increases our understanding of S100A14 functional roles in cervical cancer, which may lead to the development of a novel therapeutic target for cervical cancer.
机译:S100A14是一种EF手钙结合蛋白,据报道可对不同类型的细胞发挥其生物学作用。但是,S100A14在宫颈癌中的潜在临床意义和生物学功能尚未阐明。在这项研究中,我们首先检查了宫颈癌中S100A14表达与临床病理参数之间的相关性。接下来,我们通过采用慢病毒介导的S100A14在宫颈癌细胞中的过表达和敲低,观察了S100A14对细胞周期进程,细胞增殖,迁移和侵袭的影响。此外,我们研究了S100A14影响细胞迁移和侵袭的潜在机制。免疫组织化学分析表明S100A14的表达与国际妇产科联合会(FIGO)阶段( P = 0.025)和淋巴结(LN)转移( P = 0.001)有关)。功能分析表明,S100A14的过表达增加了G2 / M期的比例,促进了细胞的增殖,迁移和侵袭,而S100A14的抑制对上述特性表现出不利影响。机理研究表明,S100A14可以充当上皮-间质转化(EMT)的介质。 S100A14的过表达增加了 N -钙粘蛋白和波形蛋白的表达,而降低了 E -钙粘蛋白的表达。在S100A14沉默的细胞中观察到相反的结果。综上所述,我们的数据表明S100A14在宫颈癌的进展中具有至关重要的作用。这项研究显着提高了我们对S100A14在宫颈癌中的功能的了解,这可能导致开发出一种新型的宫颈癌治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号